Epidemiology of Diarrheal Diseases in Pediatric Oncology Patients
NCT02464098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2022-02-08
Summary
Diarrhea is a common problem in the pediatric population. Children with cancer are especially at increased risk for gastrointestinal infection-related morbidity and mortality due to their ongoing immunosuppression. However, the epidemiology of diarrheal illnesses in immunocompromised children is poorly understood. In the past, many or most cases of gastroenteritis have gone undiagnosed, largely due to a lack of sensitive diagnostic tests and a presumption that a large proportion of cases are due to treatment, rather than infections. The availability of new diagnostic tests that detect many gastrointestinal pathogens simultaneously offers the first opportunity to gain a comprehensive picture of the causes of infectious diarrhea in children with cancer.
Researchers at St. Jude Children's Research Hospital want to learn about the epidemiology of diarrheal diseases in pediatric oncology patients utilizing broadly multiplexed, automated PCR.
Conditions
Sponsors & Collaborators
-
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Randall T. Hayden, MD · St. Jude Children's Research Hospital
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-11-19
- Primary Completion
- 2019-11-06
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Phase I/II a Study of Decitabine in Combination With Genistein in Pediatric Relapsed or Refractory Malignancies
NCT02499861 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Protocol For Collecting Data On Patients With Childhood Cancer
NCT00684580 ·Status: RECRUITING
-
Infections in Pediatric Cancer Patients
NCT00930267 ·Status: UNKNOWN
-
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 ·Status: COMPLETED ·Phase: PHASE2
-
Next Generation Pathogen Sequencing for Prediction of Adverse Events
NCT03226158 ·Status: ACTIVE_NOT_RECRUITING
-
Therapy for Pediatric Hodgkin Lymphoma
NCT00145600 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00025259 ·Status: COMPLETED ·Phase: PHASE3
-
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
NCT00003096 ·Status: COMPLETED
-
Molecular-Guided Therapy for Relapsed and Refractory Childhood Cancer
NCT01802567 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
NCT03860376 ·Status: COMPLETED
-
Safety and Dose Finding Study of Neratinib in Children and Young Adults With Cancer That Has Returned or Not Responded to Treatment
NCT02932280 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Adolescents
NCT01249001 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Proton Therapy in Pediatric Cancer Patients
NCT03223766 ·Status: ACTIVE_NOT_RECRUITING
-
Validation Study of Pediatric Patient-Reported Outcomes
NCT03229837 ·Status: COMPLETED
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
NCT05857969 ·Status: RECRUITING ·Phase: PHASE1
-
Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid Tumors
NCT05302921 ·Status: COMPLETED ·Phase: PHASE2
-
Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors
NCT00024284 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study Combining Temozolomide, Oncovin, Camptosar and Oral Antibiotic in Children and Adolescents With Recurrent Malignancy
NCT00222443 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers
NCT06171971 ·Status: RECRUITING
-
Temozolomide in Treating Young Patients With Refractory or Recurrent Leukemia
NCT00083070 ·Status: COMPLETED ·Phase: PHASE1
-
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia
NCT00053963 ·Status: COMPLETED ·Phase: PHASE1
-
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
NCT00186875 ·Status: COMPLETED ·Phase: PHASE2
-
Different Therapies in Treating Infants With Newly Diagnosed Acute Leukemia
NCT00550992 ·Status: UNKNOWN ·Phase: NA
-
Understanding Methotrexate Induced Gastrointestinal Intolerance in Juvenile Idiopathic Arthritis and Childhood Leukemia
NCT02528435 ·Status: COMPLETED